In one single-center trial of 72 subjects using a controlled-adverse-environment model, the T4 eye drop did not meet its co-primary endpoints (ocular discomfort and inferior corneal staining) at the primary time point, but it did produce statistically significant improvements on several secondary endpoints, including central and superior corneal staining, with no adverse events reported
Certain medications, including diuretics and statins, may contribute to muscle cramps as a side effect
Once optic nerve fibers die, vision loss permanent with current treatments
Epithalon circadian sleep research suggests a different mechanism: glandular restoration rather than hormonal replacement
The Role of Diet in Antioxidant Status While supplements are powerful tools, they are meant to supplement a healthy lifestyle, not replace it
Pissios P, et al